Target intelligence / Profile preview

Ribosomal protein L19 pseudogene 2 (RPL19P2)

Target
RPL19P2
Molecular classification
Other (Pseudogene)
01

Overview

**Ribosomal protein L19 pseudogene 2 (RPL19P2) is a processed pseudogene derived from the functional ribosomal protein L19 (RPL19) gene.** It is classified as a pseudogene because it is a non-coding genomic element that resembles the functional gene but does not produce a protein product. RPL19P2 is located on human chromosome 3 and has been cataloged as HGNC:29946 by the HUGO Gene Nomenclature Committee[6][12]. There are no known biological functions, disease associations, drug interactions, or therapeutic targeting related to this pseudogene. Its primary relevance is as a genomic marker illustrating the evolutionary history of the RPL19 gene family; it does not serve as a drug target or biomarker and has no direct role in cellular function or disease[9][12]. **Key context:** - *Pseudogenes* like RPL19P2 typically do not encode functional proteins and are rarely considered as targets for drugs or disease interventions[1][9][12]. - The functional gene counterpart, *RPL19*, is a component of the 60S ribosomal subunit and is involved in protein synthesis, but RPL19P2 itself does not share these functions[1][9][12]. - No evidence supports any therapeutic or biomarker use for RPL19P2, and listing it as a target is likely incorrect or misleading[1][9][12].

Other names
RPL19_3_373RPL19P2

Beyond the preview

Go deeper on Ribosomal protein L19 pseudogene 2 (RPL19P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L19 pseudogene 2 (RPL19P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call